Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

01 déc. 2025 07h00 HE | Source: NeurAxis, Inc.

NeurAxis Secures Veterans Affairs Federal Supply Schedule Contract, Broadening Access to More Patients with Functional Abdominal Pain

CARMEL, Ind., Dec. 01, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic...
18 nov. 2025 10h33 HE | Source: Research and Markets

Cervical Dystonia Research Analysis Report 2025-2035: Market Sees Intense Competition as Ipsen, Merz, and AbbVie Advance Therapies Through Strategic Expansions

Dublin, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The "Cervical Dystonia Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035" report has been added to ...
12 nov. 2025 08h00 HE | Source: NeurAxis, Inc.

NeurAxis Announces New Medical Policy Coverage in Michigan, Adding 566,000 Covered Lives

CARMEL, Ind., Nov. 12, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic...
22 oct. 2025 06h41 HE | Source: Research and Markets

Spinal Cord Stimulators Market Insights, Competitive Landscape, and Forecast Report 2024-2032: Rising Chronic Pain and Neuropathy Cases, Advancements in Rechargeable Devices, and Regional Growth

Dublin, Oct. 22, 2025 (GLOBE NEWSWIRE) -- The "Spinal Cord Stimulators - Market Insights, Competitive Landscape, and Market Forecast - 2032" has been added to ResearchAndMarkets.com's offering. ...
01 oct. 2025 07h00 HE | Source: Comphya SA

Comphya Announces First Patient Implanted with CaverSTIM in U.S. Pilot Study at Johns Hopkins University School of Medicine

LAUSANNE, Switzerland, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Comphya SA, a clinical-stage MedTech company pioneering the first implantable neurostimulation therapy for erectile dysfunction (ED)...
24 sept. 2025 08h18 HE | Source: Magstim EGI

EGI Launches Next-Generation HD-EEG Platform to Advance Understanding of Brain Function and Stimulation

EGI Launches Next-Generation HD-EEG Platform to Advance Understanding of Brain Function and Monitoring for Neuroscience Research-New GES 500
18 sept. 2025 08h00 HE | Source: Curonix LLC

Curonix Expands the Freedom® PNS System Patient Treatment Options with the Launch of its Innovative Wearable Solution for Chronic Pain of the Head, Neck, Shoulder, and Torso

Curonix Expands the Freedom® PNS System Patient Treatment Options with the Launch of its Innovative Wearable Solution
16 sept. 2025 10h18 HE | Source: ANEUVO

ANEUVO Showcases ExaStim® Therapy At RehaCare 2025 and ISCoS 2025

Los Angeles, CA, Sept. 16, 2025 (GLOBE NEWSWIRE) -- ANEUVO today announced its participation in two of the most influential international gatherings for spinal cord injury (SCI) rehabilitation and...
$European Refractory Epilepsy Treatment Market$

16 sept. 2025 06h43 HE | Source: Research and Markets

Europe Refractory Epilepsy Treatment Research Report 2025 | Market to More Than Double to Reach $2.82 Billion by 2035, Driven by CBD Growth, Uptake of Neuromodulation Therapies, Strong R&D Pipeline

Dublin, Sept. 16, 2025 (GLOBE NEWSWIRE) -- The "Europe Refractory Epilepsy Treatment Market: Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering.The Europe...
$Asia-Pacific Refractory Epilepsy Treatment Market$

16 sept. 2025 06h25 HE | Source: Research and Markets

Asia-Pacific Refractory Epilepsy Treatment Market Research 2025 | Market to Reach $2.48 Billion by 2035 - Opportunities Fueled by a Shift from Neo-Adjuvant Approaches Driven by Diagnostic Advancements

Dublin, Sept. 16, 2025 (GLOBE NEWSWIRE) -- The "Asia-Pacific Refractory Epilepsy Treatment Market: Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering.The...

Page suivante